Global Methotrexate Drugs Market: Key Developments
market players are focused on gaining product approvals from regulatory bodies is expected to drive the global methotrexate drugs market growth. For instance, in January 2020, Aurobindo Pharma Limited., announced that its joint venture company, Eugia Pharma Specialities Limited, has received a final approval from the U.S. Food & Drug Administration (USFDA) to manufacture and market Methotrexate tablets, 2.5 mg. Methotrexate tablets are generic version of Dava Pharmaceuticals’ Rheumatrex Tablets.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients